How does Myriad conduct BART testing?
- 1 people answered
 
Edit Tags
Tags are used to find the best answers
You might also be interested in
It completely depends on the situation. In Kyphoplasty, either a spine surgeon or an interventional radiologist tries to treat a vertebral fracture using surgical cement. It effectively reduces the pain. In case of a cancer patient, the process accompanies radiofrequency ablation to remove cancer ti....
Cancer attacks your body due to a random mutation of cells that gets out of control and spreads. The majority of breast cancers are hereditary, or blind unlucky chance. Fat is not directly linked with the enhanced cancer risk factor but it affects the estrogen hormone balance in your body which play....
Direct breastfeeding could cut the chance of breast cancer by up to one fifth. It’s actually a “powerful strategy” to reduce the risk of cancer for you, especially the most aggressive types of disease. Scientists believe the high hormone levels required for lactation appears to affect cell growth, p....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
எழுதியவர்:Dr. Nitika Sharma - BDS
மதிப்பிட்டவர்:Dr. Rakesh Kumar - MBBS, MS
Mahima Chaudhary
Imagine going in for a cancer screening, and the technician turns to you and says, "We're finished, but if I push this button over here, the machine can detect even smaller cancers. But here's the hitch: You have to pay $700 if you want me to push this button."
Myriad Genetics is doing something very similar with BART tests that determine if a woman has a potentially dangerous genetic abnormality linked to breast cancers.
When testing shows that a woman carries a bad gene, she has a much higher chance of getting breast cancer. These women usually then get more frequent MRIs, ultrasounds and mammograms to detect cancer.
Myriad owns the patent on breast cancer genes and so is the only company that can test for them. It offers one test that catches most, but not all, abnormalities, and then charges nearly all patients $700 for a second test that catches the rest.
If a woman can't afford the $700 fee, she may miss an abnormality, which could mean the difference between life and death.
Myriad defends the $700 charge for its second test, called BART, even though many patients can't afford it and insurance won't pay for it.